Published • loading... • Updated
Testosterone scripts for women rise, along with denials and delays
Off-label use is rising as more than 30 trials test whether testosterone can help menopausal women with low sexual desire and other symptoms.
- The FDA will hold a public workshop on Thursday to review evidence for testosterone use in menopausal women, backed by Health Secretary Robert F. Kennedy Jr. and Defense Secretary Pete Hegseth.
- Prescriptions for testosterone among women jumped 146% from January 2023 to July 2026, yet no FDA-approved testosterone product exists for women, forcing off-label use for menopause-related symptoms.
- When Amy Swan, 55, attempted to fill her prescription in March, she faced weeks of pharmacy delays; compounded testosterone costs about $100 for a three-month supply, and patients report issues at CVS and Walgreens.
- Dr. Stephanie Faubion, director of Mayo Clinic's Center for Women's Health, warned that data does not support testosterone for muscle mass, bone density, or mood improvement, and The Menopause Society backs it only for sexual desire disorders.
- Over 30 trials are underway or planned, including a study starting later this year, as Cynthia Stuenkel, clinical professor at University of California, San Diego, hopes the FDA will prioritize evaluating a women-specific testosterone product.
Insights by Ground AI
5 Articles
5 Articles
Testosterone scripts for women rise, along with denials and delays
Women increasingly turning to testosterone therapy to manage menopause symptoms are running into unexpected prescription delays and denials at pharmacies, according to interviews with more than half a dozen doctors, nurses and patients.
·London, United Kingdom
Read Full Article
The percentage of women receiving a prescription has increased by 146% in the last three years.
Coverage Details
Total News Sources5
Leaning Left0Leaning Right2Center1Last UpdatedBias Distribution67% Right
Bias Distribution
- 67% of the sources lean Right
67% Right
C 33%
R 67%
Factuality
To view factuality data please Upgrade to Premium
